Clinical Observation on the Treatment of Brain Atrophy and Senile Dementia with Yizhi Xingnao Decoction Combined with Yizhi Pill  

作　　者：Jianzhong Tang Zhiqiang Li 

机构地区：[1]Heilongjiang Academy of Chinese Medical Sciences,Harbin 150036,Heilongjiang,China [2]Xiangda Community Health Service Center,Xiangfang District,Harbin 150036,Heilongjiang,China

出　　处：《Journal of Clinical and Nursing Research》2025年第4期299-305,共7页临床护理研究(英文)

摘　　要：Objective:To analyze the therapeutic effect of Yizhi Xingnao Decoction+Yizhi Pill on cerebral atrophy and Alzheimer’s disease(AD).Methods:Ninety-two patients with cerebral atrophy and AD who were admitted to the hospital from September 2022 to September 2024 were selected and randomly divided into two groups using a random number table.The traditional Chinese medicine(TCM)group was treated with Yizhi Xingnao Decoction+Yizhi Pill,while the western medicine group was treated with Donepezil Hydrochloride.Indicators such as total effective rate,TCM syndrome score,dementia degree score,and cognitive function score were compared between the two groups.Results:The total effective rate of the TCM group was higher than that of the Western medicine group(P<0.05).After treatment,the TCM syndrome score,dementia degree score,and cognitive function score of the TCM group were all lower than those of the Western medicine group(P<0.05).Conclusion:Yizhi Xingnao Decoction+Yizhi Pill can improve the clinical efficacy of patients with cerebral atrophy and AD,reduce disease symptoms and dementia severity,and improve patients’cognitive function.

关 键 词：Yizhi Xingnao Decoction Yizhi Pill Cerebral atrophy Alzheimer’s disease 

分 类 号：R277.7[医药卫生—中医学]